Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
05/17/1988 | US4744989 Method of preparing liposomes and products produced thereby |
05/11/1988 | EP0267051A2 Transdermal administration of amines |
05/11/1988 | EP0267038A2 Anhydrous enhanced coupling |
05/11/1988 | EP0266980A2 Pharmaceutical compositions, comprising a 2,4-diphenyl-1,3-dioxane derivative and an inhibitor of thromboxane A2 synthesis |
05/11/1988 | EP0266979A2 Therapeutic agents |
05/11/1988 | EP0266968A2 Gelled ointment of vasodilating agent |
05/10/1988 | US4743450 Angiotension converting enzyme inhibitors |
05/05/1988 | DE3637152A1 Substituted 4-aminodiphenyl sulphones and medicaments containing these compounds |
05/04/1988 | EP0266303A2 Antigestagens for the inhibition of uterine prostaglandin synthesis |
05/04/1988 | EP0266064A1 Compositions containing golgi alpha-mannosidase II inhibitors |
05/04/1988 | EP0265685A2 Combination of ACE inhibitors with calcium antagonists, and their use in medicines |
05/03/1988 | US4742054 Treatment of mammals suffering from damage to the central nervous system |
04/27/1988 | EP0265129A1 Thrombolytic therapy |
04/27/1988 | EP0264888A1 Stabilized drug compositions |
04/27/1988 | EP0264887A1 Drug compositions stabilized against oxidation and discoloration |
04/26/1988 | US4740373 Stabilization of multivitamin/trace elements formulations |
04/21/1988 | WO1988002773A1 Ex vivo effector cell activation for target cell killing |
04/21/1988 | WO1988002765A1 Penetration enhancers for transdermal delivery of systemic agents |
04/21/1988 | WO1988002632A1 Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases |
04/21/1988 | WO1988002631A1 IgE-INDUCED REGULANT (EIR) COMPOSITIONS |
04/21/1988 | WO1988002625A1 Solvent system for an ionizable pharmaceutical agent |
04/20/1988 | CN87106855A Process for the manufacturing pharmaceutical compositions |
04/19/1988 | US4738966 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
04/13/1988 | EP0263493A2 Pharmaceutic preparation to improve the gastro-intestinal resorption |
04/13/1988 | EP0263417A1 Use of hyaluronidase |
04/07/1988 | WO1988002261A1 Use of hyaluronidase |
04/06/1988 | EP0262344A2 N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions |
04/06/1988 | EP0262343A2 N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions |
04/05/1988 | US4736024 Process for preparing salt of hyaluronic acid with a pharmaceutically active substance |
04/05/1988 | CA1234754A1 Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense |
03/30/1988 | EP0261798A2 Fertility control |
03/30/1988 | EP0261693A1 Treated lipid regulator |
03/29/1988 | US4734438 Norepinephrine potentiated compositions and method of use |
03/29/1988 | US4734279 Synergistic |
03/23/1988 | EP0260527A2 Synergetic combination comprising a phosphodiesterase inhibitor and a thromboxan-A2-antagonist, and their use or manufacture |
03/23/1988 | EP0260429A2 N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions |
03/23/1988 | EP0260428A2 Cationic surfactants and pharmaceutical compositions containing them |
03/23/1988 | EP0260312A1 Method for blocking calcium channels |
03/16/1988 | EP0259904A1 Advanced anticancer therapy and cytotoxic medicaments for its implementation |
03/16/1988 | EP0259893A2 Agents for removing advanced glycosylation endproducts |
03/10/1988 | WO1988000837A3 Advanced anticancer therapy and cytotoxic medicaments for its implementation |
03/09/1988 | EP0259047A1 Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs |
03/09/1988 | EP0258672A2 Cationic surfactants and pharmaceutical compositions containing them |
03/08/1988 | US4729999 Antiestrogen therapy for symptoms of estrogen deficiency |
03/02/1988 | EP0257400A2 Pharmaceutical compositions containing cationic surfactants |
03/01/1988 | US4728721 Polymer, production and use thereof |
02/25/1988 | WO1988001180A1 Starburst conjugates |
02/25/1988 | WO1988001179A1 Starburst conjugates |
02/25/1988 | WO1988001178A1 Starburst conjugates |
02/25/1988 | WO1988001166A1 Stimulation of angiogenesis and promotion of endothelialisation |
02/24/1988 | EP0256989A1 Pharmaceutical administration systems containing chemotactic peptides |
02/24/1988 | EP0256805A2 Pharmaceutical compositions for the treatment of occlusive vascular diseases |
02/24/1988 | EP0256798A1 Anaesthetic composition |
02/24/1988 | EP0256452A2 Antiviral pharmaceutical compositions containing hypericin or pseudohypericin |
02/18/1988 | DE3724059A1 Verwendung von mono- und bicyclischen carbocyclischen und heterocyclischen carbonsaeureestern und -amiden von stickstoffhaltigen alkoholen und aminen sowie deren saeureadditionssalzen und quaternaeren ammoniumsalzen sowie von imidazolyl-carbazolen zur behandlung von psychiatrischen stoerungen wie sozialen entzugserscheinungen, manisch-depressiven psychosen, psychosen und anderen in verbindung mit stress stehende krankheiten, stoerungen des wachheitszustandes wie geriatrischen krankheitsbildern, ferner zur behandlung der rhinitis, der lungenembolie und zur verbesserung der nasalen resorption anderer wirkstoffe .......... Use of mono- and bicyclic carbocyclic and heterocyclic carbonsaeureestern and amides of nitrogen-containing alcohols and amines and ammonium salts saeureadditionssalzen thereof and quaternary, as well as imidazolyl -carbazoles for the treatment of psychiatric disorders such as social withdrawal symptoms, manic-depressive psychosis, psychosis and others in connection with stress related diseases, disorders of the alertness state as geriatric disease images, and also for the treatment of rhinitis, pulmonary embolism and for the improvement of nasal resorption other ingredients .......... |
02/11/1988 | WO1988000971A1 Recombinant vaccine |
02/11/1988 | WO1988000837A2 Advanced anticancer therapy and cytotoxic medicaments for its implementation |
02/10/1988 | EP0255803A1 Process for the prevention of re-infestation of dogs and cats by fleas |
02/02/1988 | CA1232203A1 Pharmaceutical composition containing mixtures of sodium polyacrylate and carbenoxolone sodium |
02/01/1988 | EP0192667A4 Device for initiating reperfusion treatment when heart attack symptoms are present. |
01/27/1988 | EP0254032A2 Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
01/27/1988 | CN87104429A Controlled release bases for pharmaceuticals |
01/20/1988 | EP0253717A1 Combinations of beta-blockers and pilocarpine |
01/20/1988 | EP0253202A2 Novel immunoconjugates and methods for their use in tumor therapy |
01/20/1988 | EP0253104A1 Controlled release bases for pharmaceuticals |
01/19/1988 | US4720489 Hair growth modification with ornithine decarboxylase inhibitors |
01/14/1988 | WO1988000057A1 Immunomodulating compositions and their use |
01/14/1988 | WO1988000053A1 Enhancement of the cellular immune response |
01/14/1988 | WO1988000047A1 In situ active compound assembly |
01/12/1988 | US4719239 Pharmaceutical multicomponent systems and method of preparing same |
01/07/1988 | EP0251657A2 Therapeutic compositions with galactitol as carrier |
01/07/1988 | EP0251369A2 Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them |
01/07/1988 | EP0251001A2 Stabilization of an interleukin-2 preparation for therapeutical use |
01/05/1988 | US4717717 Water soluble cellulose polymer as stabilizer |
12/30/1987 | WO1987007842A1 Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents and methods for treating diseases |
12/23/1987 | EP0249618A1 Combinations of tumor necrosis factors and antibiotics and methods for treating tumors |
12/17/1987 | WO1987007508A1 Methods and compositions for treating viral infections |
12/16/1987 | EP0249007A2 A method of screening hybridomas |
12/09/1987 | EP0248516A1 Compositions and the use of interleukin-2 and/or interferon-beta and tumour necrosis factor for combination therapy or in providing medicaments or formulations |
12/08/1987 | US4711902 Fatty acid ester |
12/07/1987 | EP0191771A4 Automatic injector assembly. |
12/03/1987 | WO1987007145A1 D-gl conjugate therapy |
12/03/1987 | WO1987007143A1 Antiprotozoan and/or antiviral cosmetic or pharmaceutical composition containing a chemical compound and process for producing such composition |
12/02/1987 | EP0247616A2 Stabilization of multivitamin/trace elements formulations |
12/02/1987 | EP0247507A2 Composition for transdermal therapeutical systems of high-ceiling diuretics, and process for producing it |
11/25/1987 | EP0246439A1 Sterile plasma substitute |
11/25/1987 | EP0246381A1 Renin inhibitors and methods for using same |
11/19/1987 | WO1987006836A1 Fibrinolytic composition |
11/19/1987 | EP0245669A2 Pharmaceutical preparation for preventing damage to living cells by free radicals, or for increasing the efficacy of organic sulphur compounds, and process for increasing the life span of isolated organs |
11/11/1987 | EP0245126A2 Percutaneous absorption preparation and process for preparing same |
11/10/1987 | US4705780 Medicaments containing pichia or extracts thereof |
11/10/1987 | US4705683 Histamine h2-antagonists, polyacrylate |
11/04/1987 | EP0244178A2 Intraocular dosage compositions and method of use |
11/04/1987 | EP0244113A1 B-lactam antibiotics |
11/04/1987 | EP0243477A1 Renin inhibitors and methods for using same |
11/03/1987 | CA1228812A1 Process for the manufacture of novel topically administrable pharmaceutical compositions |
10/28/1987 | EP0243308A2 Stabilization of the preservative Thiomersal in ophthalmic pharmaceutical compositions |
10/28/1987 | EP0242643A2 Nasal administration of drugs |
10/27/1987 | US4703060 Linolenic acid from fruit oils |
10/27/1987 | CA1228544A1 Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |